Since the present invention inflammatory bowel disease, COPD (chronic obstructive pulmonary disease), asthma, rhinitis, fibrotic diseases, psoriasis, atopic dermatitis and used in the treatment of disorders such as ultraviolet (UV)-induced skin damage of, kinase activity, in particular, salts thereof which are inhibitors of IKK2 activity, or new compounds, certain of the formula (I). None [Selection Figure]本発明は、炎症性腸疾患、COPD(慢性閉塞性肺疾患)、喘息、鼻炎、線維性疾患、乾癬、アトピー性皮膚炎および紫外線(UV)誘発性皮膚傷害のような障害の治療に用いるための、キナーゼ活性、特に、IKK2活性の阻害剤である、式(I)のある特定の新規化合物、またはその塩に関する。【選択図】なし
